Brainstorm Cell Therapeutics reported $12K in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Adamis Pharmaceuticals ADMP:US 15.05K 20
Biogen BIIB:US $ 0.1M 0M
Brainstorm Cell Therapeutics BCLI:US $ 0.01M 0M
Cerulean Pharma CERU:US $ 0.01M 0M
Cytokinetics CYTK:US $ 0.08M 0M
Halozyme Therapeutics HALO:US $ 0.14M 0M
Idera Pharmaceuticals IDRA:US $ 0.05M 0M